VC
Value Add VC
โšกHomePulseโšกHelpful Apps๐Ÿ“Blog
โ† Value Add PulseIPO

IPO Party Faces Down Volatility, Sinking SpaceX

Newcomer's weekly analysis asks whether 2026's red-hot IPO window can survive SpaceX's post-listing stock collapse and a broader volatility spike, with several AI-adjacent companies still queued to list this year.

July 17, 2026
Published
~42%
SpaceX post-peak decline
SpaceX, Csquare, Std Nuclear
Recent debuts cited
TC
Trace Cohen
Early-stage VC & angel ยท Founder, New York Venture Partners
July 17, 2026
2 min read
ShareXLinkedInEmail
THE RUNDOWN
1

Newcomer's July 17 analysis frames 2026's IPO market at an inflection point: a year of blockbuster debuts -- SpaceX, Csquare, Standard Nuclear among them -- now facing its first real test as SpaceX's post-IPO stock craters and volatility, measured by the VIX, spikes

2

The piece argues bankers and issuers have priced 2026 IPOs on continuation of 2025's AI-driven risk appetite, an assumption SpaceX's roughly 42% post-peak decline and Csquare's below-range debut both complicate

3

OpenAI's confidential S-1, Anthropic's reported IPO preparations and a wave of smaller AI-infrastructure listings are all still in the pipeline, meaning the window's next few prints will set the tone for a much larger slate of AI-adjacent companies waiting to list

4

Newcomer's framing echoes what happened in 2021-2022, when a hot IPO window closed abruptly once early debuts started trading down -- a pattern issuers and bankers are now explicitly watching for signs of repeating

TC
The VC Read ยท Trace's TakeTrace Cohen

Every banker marketing a 2026-2027 IPO right now is quietly running the same math: if SpaceX can lose 42% of its post-IPO pop in six weeks, what does that do to the pricing conversation for OpenAI or Anthropic when they actually file publicly? The window hasn't closed yet, but the risk premium bankers build into the next round of roadshows just went up materially, and founders who assumed 2025's multiples were the new normal need to replan around a public market that's suddenly much less forgiving.

Newcomer's weekly analysis, published July 17, poses the question hanging over every banker and issuer currently planning a listing: can 2026's red-hot IPO window survive SpaceX's post-listing stock collapse and a broader spike in market volatility? The piece frames the year's run of blockbuster AI-and-space-adjacent debuts -- SpaceX, Csquare's data-center listing, Standard Nuclear's fuel-supply-chain offering -- as having been priced on an assumption that 2025's AI-driven risk appetite would simply continue uninterrupted into the public markets.

That assumption is now being tested in real time. SpaceX has fallen roughly 42% from its post-IPO peak, back near its original offer price within six weeks of listing. Csquare debuted below its price range and opened down. Standard Nuclear needed a 58% size cut to get its offering done at all. Each data point individually has its own explanation, but Newcomer's framing treats them collectively as the first real stress test of a window that had, until this month, priced almost everything for perfection.

โ€œSpaceX has fallen roughly 42% from its post-IPO peak, back near its original offer price within six weeks of listing.โ€

The stakes extend well beyond the companies that have already listed. OpenAI's confidential S-1, Anthropic's own reported IPO preparations -- disclosed indirectly through Menlo Ventures' recent 40%-plus IRR scoop tied to its Anthropic stake -- and a broader wave of AI-infrastructure companies are all still queued behind this year's early movers. How the next few prints trade will set the tone bankers use to price the entire remaining slate, the same dynamic that played out in 2021 when early SPAC and tech debuts trading down triggered a broader window closure that took the better part of two years to reopen.

The comparison to 2021-2022 is instructive but not exact: this year's IPO wave is anchored in AI infrastructure with genuine, if early, revenue growth at companies like SpaceX and Databricks, rather than the pre-revenue SPAC mania that characterized the prior cycle's excess. But the pattern -- hot window, early debuts stumble, subsequent issuers reprice down or pull altogether -- is one every banker currently marketing a 2026-2027 listing is now explicitly watching for.

The bear case: a handful of rocky debuts in a single asset class (space, data-center real estate, nuclear fuel) doesn't necessarily predict how a fundamentally different company like OpenAI or Anthropic would trade, and IPO windows have reopened faster in cycles with genuine underlying revenue growth than in pure-hype cycles. What to watch next: whether the next major AI-adjacent IPO prices below or above its range, and whether that outcome shifts OpenAI's or Anthropic's own listing timelines.

ShareXLinkedInEmail
More onSpaceX โ†’

Originally reported by Newcomer. Analysis and editorial commentary by Value Add Pulse.

โ† Back to Pulse

THE WIRE in your inboxโ€” Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO$225 median target

Wall Street's $800 SpaceX Target Meets a 42% Crash

Eighteen banks issued SpaceX targets as high as $800, but the stock has fallen ~42% from its post-IPO peak and now trades near its $135 offer price, a gap that looks like herd behavior, not analysis.

IPOIPO odds: 18.5%

Apple's Trade-Secrets Suit Threatens OpenAI's IPO

Apple's trade-secrets lawsuit against OpenAI, alleging its hardware chief directed former Apple staff to bring 'actual parts' to interviews, has already cut Wall Street's odds of a 2026 OpenAI IPO from roughly 22% to 18.5%.

IPO

12 New S-1 Filings Show a Micro-Cap Biotech Wave

A dozen new SEC S-1 and S-1/A filings this week, dominated by small biotech and biopharma names, show a steady drip of micro-cap public offerings continuing well below the AI-mega-cap headlines dominating the IPO conversation.

@Trace_Cohenยทt@nyvp.com